Literature DB >> 33374919

Thapsigargin-From Traditional Medicine to Anticancer Drug.

Agata Jaskulska1,2, Anna Ewa Janecka2, Katarzyna Gach-Janczak2.   

Abstract

A sesquiterpene lactone, thapsigargin, is a phytochemical found in the roots and fruits of Mediterranean plants from Thapsia L. species that have been used for centuries in folk medicine to treat rheumatic pain, lung diseases, and female infertility. More recently thapsigargin was found to be a potent cytotoxin that induces apoptosis by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA) pump, which is necessary for cellular viability. This biological activity encouraged studies on the use of thapsigargin as a novel antineoplastic agent, which were, however, hampered due to high toxicity of this compound to normal cells. In this review, we summarized the recent knowledge on the biological activity and molecular mechanisms of thapsigargin action and advances in the synthesis of less-toxic thapsigargin derivatives that are being developed as novel anticancer drugs.

Entities:  

Keywords:  anticancer activity; apoptosis; cytotoxin; mipsagargin; prodrug; prostate-specific antigen; prostate-specific membrane antigen; sarcoplasmic/endoplasmic reticulum Ca2+ ATPase; thapsigargin; unfold protein response

Year:  2020        PMID: 33374919     DOI: 10.3390/ijms22010004

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  15 in total

1.  Effects of endoplasmic reticulum stress-mediated CREB3L1 on apoptosis of glioma cells.

Authors:  Zhao Yan; Yaxin Hu; Yiwei Zhang; Qian Pu; Liangzhao Chu; Jian Liu
Journal:  Mol Clin Oncol       Date:  2022-02-15

Review 2.  Autophagy in health and disease: From molecular mechanisms to therapeutic target.

Authors:  Guang Lu; Yu Wang; Yin Shi; Zhe Zhang; Canhua Huang; Weifeng He; Chuang Wang; Han-Ming Shen
Journal:  MedComm (2020)       Date:  2022-07-10

3.  Mitochondria in the line of fire.

Authors:  Saverio Marchi; Paolo Pinton
Journal:  Cell Death Differ       Date:  2022-07-13       Impact factor: 12.067

Review 4.  Evolution of 3-(4-hydroxyphenyl)indoline-2-one as a scaffold for potent and selective anticancer activity.

Authors:  Matthew W Boudreau; Paul J Hergenrother
Journal:  RSC Med Chem       Date:  2022-05-09

5.  hnRNP-A1 binds to the IRES of MELOE-1 antigen to promote MELOE-1 translation in stressed melanoma cells.

Authors:  Maud Charpentier; Emilie Dupré; Agnès Fortun; Floriane Briand; Mike Maillasson; Emmanuelle Com; Charles Pineau; Nathalie Labarrière; Catherine Rabu; François Lang
Journal:  Mol Oncol       Date:  2021-09-12       Impact factor: 7.449

6.  Costunolide, a Sesquiterpene Lactone, Suppresses Skin Cancer via Induction of Apoptosis and Blockage of Cell Proliferation.

Authors:  Sung Ho Lee; Young-Chang Cho; Jae Sung Lim
Journal:  Int J Mol Sci       Date:  2021-02-19       Impact factor: 5.923

7.  Mitochondria Fusion upon SERCA Inhibition Prevents Activation of the NLRP3 Inflammasome in Human Monocytes.

Authors:  Ana Catarina Pereira; Nuno Madeira; Sofia Morais; António Macedo; Maria Teresa Cruz; Cláudia M F Pereira
Journal:  Cells       Date:  2022-01-27       Impact factor: 6.600

8.  Store-Operated Ca2+ Entry Contributes to Piezo1-Induced Ca2+ Increase in Human Endometrial Stem Cells.

Authors:  Vladislav Chubinskiy-Nadezhdin; Svetlana Semenova; Valeria Vasileva; Alla Shatrova; Natalia Pugovkina; Yuri Negulyaev
Journal:  Int J Mol Sci       Date:  2022-03-29       Impact factor: 5.923

Review 9.  MALAT1-related signaling pathways in colorectal cancer.

Authors:  Wen-Wen Xu; Jin Jin; Xiao-Yu Wu; Qing-Ling Ren; Maryam Farzaneh
Journal:  Cancer Cell Int       Date:  2022-03-19       Impact factor: 5.722

10.  Aerial View of the Association Between m6A-Related LncRNAs and Clinicopathological Characteristics of Pancreatic Cancer.

Authors:  Bowen Huang; Jianzhou Liu; Jun Lu; Wenyan Gao; Li Zhou; Feng Tian; Yizhi Wang; Mingjie Luo; Dong Liu; Congyong Xie; Ziyu Xun; Chengxi Liu; Yu Wang; Haibo Ma; Junchao Guo
Journal:  Front Oncol       Date:  2022-01-03       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.